TEVA SAYS NOVARTIS UNIT SEEKS TO DELAY FDA APPROVAL FOR TEVA'S GENERIC ZOCOR

Novartis' generic unit, Sandoz Inc, filed a complaint in a US court against a decision granting Teva Pharmaceutical Industries Ltd a 180-day exclusivity deal for Teva's generic version of Merck's cholesterol-fighting drug Zocor. Sandoz asked the US District Court for the District of Columbia to order the US Food and Drug Administration to delay Teva's generic version until the FDA approves Sandoz's version.

Euro2Day (http://www.euro2day.gr/articlesfna/16501875/)